Vasculitis and the NLRP3 inflammasome

Author:

Hamzaoui Kamel1,Hamzaoui Agnès12

Affiliation:

1. Laboratory Research 19SP02 ‘Chronic Pathologies: From Genome to Management’, Department of Respiratory Diseases, Tunis El Manar University

2. Department of Respiratory Diseases, Pavillon B. Abderrahman Mami Hospital, Tunis, Tunisia

Abstract

Purpose of review Vasculitis are a group of heterogeneous conditions characterized by chronic inflammation of blood vessels, leading to tissue destruction and organ failure. Vasculitis is an inflammatory process in which immune effector cells infiltrate blood vessels and surrounding tissues. The involvement of inflammasomes seems to occur during inflammatory processes. Recent findings Studies have emphasized that genetic susceptibility is an important aspect of the pathogenesis of vasculitis. The innate immune system is a major contributor to these inflammatory diseases, suggesting that the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome plays a key role. NLRP3 activation causes the assembly of a large multiprotein and leads to the secretion of bioactive interleukin (IL)-1β and IL-18 as well as the induction of inflammatory cell death, termed pyroptosis. Accumulating evidence confirms the involvement of this cascade in sterile inflammatory diseases and other vascular diseases. Summary In this review, we will summarize the current state of knowledge regarding the role of NLRP3 inflammasome in vascular diseases, and discuss the potential of the NLRP3 inflammasome as a therapeutic target.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Rheumatology

Reference76 articles.

1. Biomarkers in vasculitis;Hatemi;Curr Opin Rheumatol,2018

2. Biological therapy for systemic vasculitis: a systematic review;Silva-Fernández;Semin Arthritis Rheum,2014

3. Kawasaki disease;Newburger;J Am Coll Cardiol,2016

4. Vasculitis syndromediagnosis and therapy;Okazaki;J Gen Fam Med,2017

5. The up-to-date pathophysiology of Kawasaki disease;Hara;Clin Transl Immunol,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3